Abstract
The research study team may be notified about an impending audit by telephone or in writing. In turn, the research site should notify all involved parties, including the sponsor, CRO, and IRB. Sponsor audits are done to be certain that the site is collecting accurate information which may be crucial for FDA approval. IRB audits instead focus on subject safety, welfare, privacy, and confidentiality. An FDA audit can occur randomly or be triggered if the site is a top enrolling site, if the site is recommended to the FDA by the sponsor or CRO, if the site has had prior quality issues, or if there are public health issues concerning that research. An FDA audit, also called an inspection, follows very specific protocols of which the site should be informed. An audit is a time to hone the clinical research skills and appreciate the clarity that an audit can bring.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
East, C. (2018). Acing an Audit. In: Developing a Successful Clinical Research Program. Springer, Cham. https://doi.org/10.1007/978-3-319-54693-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-54693-3_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54692-6
Online ISBN: 978-3-319-54693-3
eBook Packages: MedicineMedicine (R0)